[ Price : $8.95]
CBER executives say FDA is aware of a relatively small number of cases in which people treated with CAR-T products developed secon...[ Price : $8.95]
FDA issues a finalized guidance on updating ANDA labels following revisions to the reference-listed drug label.[ Price : $8.95]
CDER and CBER say they have accepted the first artificial intelligence, digital health technology, and neuroscience project in the...[ Price : $8.95]
FDA publishes a comprehensive Veterinary International Conference on Harmonization guidance on good manufacturing practice for ani...[ Price : $8.95]
FDA purchases a subscription to digiM Solutions I2S software for the CDER Division of Product Quality and Research.[ Price : $8.95]
Five stakeholders suggest possible topics for an upcoming FDA workshop on innovative drug clinical trials.[ Price : $8.95]
Twenty-eight non-profit groups representing the CBD (cannabidiol) and hemp industries call on Congress to hold a hearing to unders...[ Price : $8.95]
FDA publishes an updated guidance incorporating GDUFA 3 performance goals on amendments and requests for final approval to tentati...